Cargando…

Asthma control factors in the Gulf Cooperation Council (GCC) countries and the effectiveness of ICS/LABA fixed dose combinations: a dual rapid literature review

BACKGROUND: Asthma control is influenced by multiple factors. These factors must be considered when appraising asthma interventions and their effectiveness in the Gulf Cooperation Council (GCC) countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates [UAE]). Based on published...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noibi, Saeed, Mohy, Ahmed, Gouhar, Raef, Shaker, Fadel, Lukic, Tamara, Al-Jahdali, Hamdan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414753/ https://www.ncbi.nlm.nih.gov/pubmed/32770967 http://dx.doi.org/10.1186/s12889-020-09259-3

Ejemplares similares

Budget Impact Analysis of Mepolizumab for Eligible Patients in the Setting of a Severe Asthma Clinic Within Dubai Health Authority (DHA)
por: Mahboub, Bassam, et al.
Publicado: (2022)

Diagnosis and Management of Hypothyroidism in Gulf Cooperation Council (GCC) Countries
por: Alzahrani, Ali S., et al.
Publicado: (2020)

Dynamics of COVID-19 in the Gulf Cooperation Council (GCC) countries
por: Abusam, Abdallah
Publicado: (2022)

Child maltreatment prevention readiness in Gulf Cooperation Council (GCC) countries
por: Al Eissa, Majid, et al.
Publicado: (2019)

Prevalence and management of hyperkalemia in chronic kidney disease and heart failure patients in the Gulf Cooperation Council (GCC)
por: AlSahow, Ali, et al.
Publicado: (2023)

Life-Cycle Assessment of Polypropylene Production in the Gulf Cooperation Council (GCC) Region
por: Alsabri, Amzan, et al.
Publicado: (2021)

Undergraduate medical research in the Gulf Cooperation Council (GCC) countries: a descriptive study of the students’ perspective
por: Sayedalamin, Zaid, et al.
Publicado: (2018)

Coronavirus disease of 2019 (COVID-19) in the Gulf Cooperation Council (GCC) countries: Current status and management practices
por: Alandijany, Thamir A., et al.
Publicado: (2020)

Barriers and facilitators to conducting economic evaluation studies of Gulf Cooperation Council (GCC) countries: a survey of researchers
por: Almazrou, Saja H., et al.
Publicado: (2021)

Corporate governance mechanisms, royal family ownership and corporate performance: evidence in gulf cooperation council (GCC) market
por: Tawfik, Omar Ikbal, et al.
Publicado: (2022)

Nexus Between Demographic Change and Elderly Care Need in the Gulf Cooperation Council (GCC) Countries: Some Policy Implications
por: Khan, Hafiz T. A., et al.
Publicado: (2017)

Prevalence of obesity among school-age children and adolescents in the Gulf cooperation council (GCC) states: a systematic review
por: Al Hammadi, Hanouf, et al.
Publicado: (2019)

Diagnosis and management of growth disorders in Gulf Cooperation Council (GCC) countries: Current procedures and key recommendations for best practice
por: Al Herbish, Abdullah S., et al.
Publicado: (2016)

Influence of Age on 2040 Cancer Burden in the Older Population of the Gulf Cooperation Council (GCC) Countries: Public Health Implications
por: Cheema, Sohaila, et al.
Publicado: (2021)

Progress of the Gulf Cooperation Council (GCC) Countries Towards Achieving the 95-95-95 UNAIDS Targets: A Review
por: Awaidy, Salah Al, et al.
Publicado: (2023)

Current Epidemiological Characteristics of Imported Malaria, Vector Control Status and Malaria Elimination Prospects in the Gulf Cooperation Council (GCC) Countries
por: Iqbal, Jamshaid, et al.
Publicado: (2021)

Correction: Progress of the Gulf Cooperation Council (GCC) Countries Towards Achieving the 95–95–95 UNAIDS Targets: A Review
por: Al Awaidy, Salah, et al.
Publicado: (2023)

EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
por: Buhl, Roland, et al.
Publicado: (2023)

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
por: Hizawa, Nobuyuki
Publicado: (2015)

Establishing a marine monitoring programme to assess antibiotic resistance: A case study from the Gulf Cooperation Council (GCC) region()
por: Light, Edel, et al.
Publicado: (2022)

Assessing the contribution of nine preventable risk factors attributed to the burden of early onset colorectal cancer in Gulf Cooperation Council (GCC) countries
por: Ramadan, Majed
Publicado: (2023)

Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler
por: Price, David B., et al.
Publicado: (2016)

Forecasting the SARS COVID-19 pandemic and critical care resources threshold in the Gulf Cooperation Council (GCC) countries: population analysis of aggregate data
por: Al-Aamri, Amira K, et al.
Publicado: (2021)

The incidence of lung cancer in the Gulf Cooperation Council countries
por: Al-Hamdan, Nasser, et al.
Publicado: (2006)

Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas
por: Al-Saleh, Yousef, et al.
Publicado: (2021)

Investigating the role of export product diversification for renewable, and non-renewable energy consumption in GCC (gulf cooperation council) countries: does the Kuznets hypothesis exist?
por: Fatima, Tehreem, et al.
Publicado: (2021)

Knowledge, attitude, and perception of oral and maxillofacial surgery specialty amongst healthcare professionals, and the General Public from a Gulf Cooperation Council (GCC) Country
por: Kamal, Mohammad, et al.
Publicado: (2021)

EPH207 Factors Associated with COVID-19 Infections and Deaths in the Gulf Cooperation Council (GCC) Countries: A Time Series Cross-Section Analysis
por: Alam, M., et al.
Publicado: (2023)

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
por: Singh, Dave, et al.
Publicado: (2019)

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
por: Rodrigo, Gustavo J, et al.
Publicado: (2017)

The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1
por: Janeva, Elena Jovanovska, et al.
Publicado: (2015)

Correction to: Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas
por: Al-Saleh, Yousef, et al.
Publicado: (2021)

Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?
por: Oh, Yeon-Mok
Publicado: (2017)

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
por: Vanfleteren, Lowie, et al.
Publicado: (2018)

Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
por: Vanfleteren, Lowie E.G.W., et al.
Publicado: (2019)

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device
por: Tashkin, Donald P., et al.
Publicado: (2021)

Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis
por: Aziz, Mohamed Ismail Abdul, et al.
Publicado: (2018)

Meningococcal disease within the Gulf Cooperation Council Countries
por: Al Awaidy, Salah, et al.
Publicado: (2023)

Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics
por: Benfante, Alida, et al.
Publicado: (2016)

Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
por: Beasley, Richard, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s1nngmk1qq8cs5b60es4ebj6f4